Paper Details

  1. Home
  2. Paper Details

Pasireotide for the Medical Management of Feline Hypersomatotropism.

Author: ChurchD, ForcadaY, GostelowR, NiessenS J M, SchmidH A, ScudderC J

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Short-acting pasireotide rapidly decreased IGF-1 in cats with hypersomatotropism (HST) and insulin-dependent diabetes, associated with increased insulin sensitivity.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Feline hypersomatotropism (HST) is a cause of diabetes mellitus in cats. Pasireotide is a novel multireceptor ligand somatostatin analog that improves biochemical control of humans with HST. HYPOTHESIS/OBJECTIVES: Pasireotide improves biochemical control of HST and diabetes mellitus in ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4895359/

データ提供：米国国立医学図書館（NLM）

Pasireotide for Feline Hypersomatotropism

This study investigates the use of pasireotide, a promising drug, to treat feline hypersomatotropism (HST) – a condition that disrupts the delicate balance of hormones in cats, often leading to diabetes. It's like finding a rare oasis in the vast desert of feline health problems. The researchers aim to determine if pasireotide can effectively manage HST and diabetes in these furry patients.

Pasireotide's Positive Effects

The study demonstrates that pasireotide significantly reduces IGF-1 levels in cats with HST and diabetes. This leads to improved insulin sensitivity, which is like finding a cool spring in the desert – a refreshing relief for these cats struggling with diabetes. These findings suggest pasireotide could be a valuable tool for managing feline HST and diabetes.

Implications for Feline Health

This research holds great potential for improving the lives of cats suffering from HST and diabetes. It highlights the importance of seeking veterinary care for these conditions and underscores the potential benefits of pasireotide. We can think of it like a skilled guide leading a caravan through the desert – providing much-needed support and care to these beloved companions.

Dr.Camel's Conclusion

This research sheds light on a promising treatment option for cats with HST and diabetes. It's like discovering a hidden well in the desert, providing much-needed relief for these animals. Pasireotide could bring a new wave of hope for feline health and well-being.
Date :
  1. Date Completed 2016-04-22
  2. Date Revised 2022-03-31
Further Info :

Pubmed ID

25945588

DOI: Digital Object Identifier

PMC4895359

Related Literature

Article Analysis
・Effects of pasireotide injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.